Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Лечение желудочковых аритмий при инфаркте миокарда: история вопроса - Журнал Терапевтический архив №9 Вопросы кардиологии 2025
Лечение желудочковых аритмий при инфаркте миокарда: история вопроса
Окишева Е.А., Пятигорец Е.С., Окишев Д.Н., Трушина О.Ю. Лечение желудочковых аритмий при инфаркте миокарда: история вопроса. Терапевтический архив. 2025;97(9):814–818. DOI: 10.26442/00403660.2025.09.203348
© ООО «КОНСИЛИУМ МЕДИКУМ», 2025 г.
© ООО «КОНСИЛИУМ МЕДИКУМ», 2025 г.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Желудочковые аритмии являются распространенным и опасным для жизни осложнением инфаркта миокарда. В статье описана история изучения и внедрения в практику методов лечения желудочковых аритмий при инфаркте миокарда, а также обсуждаются возможные перспективы развития данного направления в будущем.
Ключевые слова: инфаркт миокарда, аритмии, желудочковые аритмии, антиаритмические препараты, электрокардиостимулятор, имплантируемый кардиовертер-дефибриллятор, диагностика, прогноз, история медицины
Keywords: myocardial infarction, arrhythmias, ventricular arrhythmias, antiarrhythmic drugs, pacemaker, implantable cardioverter-defibrillator, diagnostics, prognosis, history of medicine
Ключевые слова: инфаркт миокарда, аритмии, желудочковые аритмии, антиаритмические препараты, электрокардиостимулятор, имплантируемый кардиовертер-дефибриллятор, диагностика, прогноз, история медицины
________________________________________________
Keywords: myocardial infarction, arrhythmias, ventricular arrhythmias, antiarrhythmic drugs, pacemaker, implantable cardioverter-defibrillator, diagnostics, prognosis, history of medicine
Полный текст
Список литературы
1. Traube L. Ueber Herzbewegungsstoerungen bei Herzkrankheiten. Berliner Klinische Wochenschrift. 1896;33:285-8.
2. Lewis T. On the disturbances of the heartbeat in myocardial disease. Lancet. 1906;1:1249-52.
3. Cunningham RH. The cause of death from industrial accidents. NY Med J. 1899;70:581-7;615-22.
4. Herrick JB. Comments on the treatment of heart disease. JAMA. 1928;91(23):1761-3. DOI:10.1001/jama.1928.02700230001001
5. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912;LIX(23):2015-22. DOI:10.1001/jama.1912.04270120001001
6. Levine SA. Coronary thrombosis: its various clinical features. Baltimore: Williams & Wilkins, 1929.
7. Zoll PM, Linenthal AJ, Gibson W, et al. Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med. 1956;254:727-32. DOI:10.1056/NEJM195604192541601
8. Harrison TR, Resnik WH. Etiologic aspects of heart disease (including treatment of the different etiologic types). In: Harrison TR, Beeson PB, Thorn GW, et al. (eds). Principles of internal medicine. New York: Blackiston, 1950; p. 1287-9.
9. Braunwald E. The treatment of acute myocardial infarction: the Past, the Present, and the Future. Eur Heart J Acute Cardiovasc Care. 2012;1(1):9-12. DOI:10.1177/2048872612438026.
10. Rosenbaum MB, Chiale PA, Halpern MS, et al. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976;38(7):934-44. DOI:10.1016/0002-9149(76)90807-9
11. Hohnloser SH, Verrier RL, Lown B, et al. Effect of hypokalemia on susceptibility to ventricular fibrillation in the normal and ischemic canine heart. Am Heart J. 1986;112(1):32-5. DOI:10.1016/0002-8703(86)90674-5
12. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971;44(1):130-42. DOI:10.1161/01.cir.44.1.130
13. Zipes DP. Treatment of arrhythmias in myocardial infarction. Arch Intern Med. 1969;124(1):101-9. DOI:10.1001/archinte.1969.00300170103020
14. Killip T. Arrhythmias in Myocardial Infarction. Med Clin North Am. 1976;60(2):233-44. DOI:10.1016/s0025-7125(16)31907-1
15. Исаев Г.О., Васин А.А., Миронова О.Ю. Дефибрилляция: история и перспективы. Терапевтический архив. 2021;93(9):1138-43 [Isaev GO, Vasin AА, Mironova OI. History and perspectives of the defibrillation. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(9):1138-43 (in Russian)]. DOI:10.26442/00403660.2021.09.201030
16. Чазов Е.И., Николаева Л.Ф., Руда М.Я. Некоторые новые аспекты лечения больных острым инфарктом миокарда. Кардиология. 1977;(2):5-11 [Chazov EI, Nikolaeva LF, Ruda MYa. Some new aspects of the treatment of patients with acute myocardial infarction. Kardiologiya. 1977;(2):5-11 [(in Russian)].
17. Matchett M, Sears S, Hazelton G, et al. The implantable cardioverter defibrillator: its history, current psychological impact and future. Expert Rev Me Devices. 2009;6(1):43-50. DOI:10.1586/17434440.6.1.43
18. Stevenson WG, Desai AS, Almendral JM, et al. Multicenter Unsustained Tachycardia Trial Investigators. Catheter ablation of ventricular tachycardia in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial. Circulation. 2004;109(2):160-6.
19. Morady F, Harvey M, Kalbfleisch SJ, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993;87:363-72. DOI:10.1161/01.cir.87.2.363
20. Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. J Interv Card Electrophysiol. 2020;59(1):145-298. DOI:10.1007/s10840-019-00663-3
21. Scrocco C, Bezzina CR, Ackerman MJ, et al. Genetics and genomics of arrhythmic risk: current and future strategies to prevent sudden cardiac death. Nat Rev Cardiol. 2021;18(11):774-84. DOI:10.1038/s41569-021-00555-y
22. Чазов Е.И., ред. Инфаркт миокарда: Монография. М.: Медицина, 1971 [Chazov EI, red. Infarkt miokarda: Monografia. Moscow: Meditsina, 1971 (in Russian)].
23. Чазов Е.И., Матвеева Л.С., Мазаев А.В., и др. Внутрикоронарное назначение фибринолизина при остром инфаркте миокарда. Терапевтический архив. 1976;48(4):8-17 [Chazov EI, Matveeva LS, Mazaev AV, et al. Intracoronary fibrinolysin administration in acute myocardial infarction. Terapevticheskii Arkhiv (Ter. Arkh.). 1976;48(4):8-17 [(in Russian)].
24. Шахнович Р.М., Руда М.Я. Эволюция лечения инфаркта миокарда за последние десятилетия. Значение работ Е.И. Чазова. Терапевтический архив. 2019;91(6):25-33 [Shakhnovich RM, Ruda MYa. The evolution of myocardial infarction treatment over the past decades. The significance of E.I. Chazov works. Terapevticheskii Arkhiv (Ter. Arkh.). 2019;91(6):25-33 (in Russian)]. DOI:10.26442/00403660.2019.06.000291
25. Лебедев Д.С., Михайлов Е.Н., Неминущий Н.М., и др. Желудочковые нарушения ритма. Желудочковые тахикардии и внезапная сердечная смерть. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;26(7):4600 [Lebedev DS, Mikhailov EN, Neminuschiy NM, et al. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines. Russian Journal of Cardiology. 2021;26(7):4600 (in Russian)]. DOI:10.15829/1560-4071-2021-4600
26. Frampton J, Ortengren AR, Zeitler EP. Arrhythmias After Acute Myocardial Infarction. Yale J Biol Med. 2023;96(1):83-94. DOI:10.59249/LSWK8578
27. Campbell RW, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J. 1981;46(4):351-7. DOI:10.1136/hrt.46.4.351
28. Winkle RA, Thomas A. The Automatic implantable cardioverter defibrillator: The U.S. experience. In: P. Brugada, H.J. Wellens, eds. Cardiac arrhythmias: where to go from here? Futura Publishing Company, Inc., Mount Kisco, New York; 1987; p. 663-80.
29. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126. DOI:10.1093/eurheartj/ehac262
30. Maron BJ, Estes NAM, Rowin EJ, et al. Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2023;82(4):353-73. DOI:10.1016/j.jacc.2023.04.056
2. Lewis T. On the disturbances of the heartbeat in myocardial disease. Lancet. 1906;1:1249-52.
3. Cunningham RH. The cause of death from industrial accidents. NY Med J. 1899;70:581-7;615-22.
4. Herrick JB. Comments on the treatment of heart disease. JAMA. 1928;91(23):1761-3. DOI:10.1001/jama.1928.02700230001001
5. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912;LIX(23):2015-22. DOI:10.1001/jama.1912.04270120001001
6. Levine SA. Coronary thrombosis: its various clinical features. Baltimore: Williams & Wilkins, 1929.
7. Zoll PM, Linenthal AJ, Gibson W, et al. Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med. 1956;254:727-32. DOI:10.1056/NEJM195604192541601
8. Harrison TR, Resnik WH. Etiologic aspects of heart disease (including treatment of the different etiologic types). In: Harrison TR, Beeson PB, Thorn GW, et al. (eds). Principles of internal medicine. New York: Blackiston, 1950; p. 1287-9.
9. Braunwald E. The treatment of acute myocardial infarction: the Past, the Present, and the Future. Eur Heart J Acute Cardiovasc Care. 2012;1(1):9-12. DOI:10.1177/2048872612438026.
10. Rosenbaum MB, Chiale PA, Halpern MS, et al. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976;38(7):934-44. DOI:10.1016/0002-9149(76)90807-9
11. Hohnloser SH, Verrier RL, Lown B, et al. Effect of hypokalemia on susceptibility to ventricular fibrillation in the normal and ischemic canine heart. Am Heart J. 1986;112(1):32-5. DOI:10.1016/0002-8703(86)90674-5
12. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971;44(1):130-42. DOI:10.1161/01.cir.44.1.130
13. Zipes DP. Treatment of arrhythmias in myocardial infarction. Arch Intern Med. 1969;124(1):101-9. DOI:10.1001/archinte.1969.00300170103020
14. Killip T. Arrhythmias in Myocardial Infarction. Med Clin North Am. 1976;60(2):233-44. DOI:10.1016/s0025-7125(16)31907-1
15. Isaev GO, Vasin AА, Mironova OI. History and perspectives of the defibrillation. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(9):1138-43 (in Russian). DOI:10.26442/00403660.2021.09.201030
16. Chazov EI, Nikolaeva LF, Ruda MYa. Some new aspects of the treatment of patients with acute myocardial infarction. Kardiologiya. 1977;(2):5-11 [(in Russian).
17. Matchett M, Sears S, Hazelton G, et al. The implantable cardioverter defibrillator: its history, current psychological impact and future. Expert Rev Me Devices. 2009;6(1):43-50. DOI:10.1586/17434440.6.1.43
18. Stevenson WG, Desai AS, Almendral JM, et al. Multicenter Unsustained Tachycardia Trial Investigators. Catheter ablation of ventricular tachycardia in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial. Circulation. 2004;109(2):160-6.
19. Morady F, Harvey M, Kalbfleisch SJ, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993;87:363-72. DOI:10.1161/01.cir.87.2.363
20. Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. J Interv Card Electrophysiol. 2020;59(1):145-298. DOI:10.1007/s10840-019-00663-3
21. Scrocco C, Bezzina CR, Ackerman MJ, et al. Genetics and genomics of arrhythmic risk: current and future strategies to prevent sudden cardiac death. Nat Rev Cardiol. 2021;18(11):774-84. DOI:10.1038/s41569-021-00555-y
22. Chazov EI, red. Infarkt miokarda: Monografia. Moscow: Meditsina, 1971 (in Russian).
23. Chazov EI, Matveeva LS, Mazaev AV, et al. Intracoronary fibrinolysin administration in acute myocardial infarction. Terapevticheskii Arkhiv (Ter. Arkh.). 1976;48(4):8-17 [(in Russian).
24. Shakhnovich RM, Ruda MYa. The evolution of myocardial infarction treatment over the past decades. The significance of E.I. Chazov works. Terapevticheskii Arkhiv (Ter. Arkh.). 2019;91(6):25-33 (in Russian). DOI:10.26442/00403660.2019.06.000291
25. Lebedev DS, Mikhailov EN, Neminuschiy NM, et al. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines. Russian Journal of Cardiology. 2021;26(7):4600 (in Russian). DOI:10.15829/1560-4071-2021-4600
26. Frampton J, Ortengren AR, Zeitler EP. Arrhythmias After Acute Myocardial Infarction. Yale J Biol Med. 2023;96(1):83-94. DOI:10.59249/LSWK8578
27. Campbell RW, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J. 1981;46(4):351-7. DOI:10.1136/hrt.46.4.351
28. Winkle RA, Thomas A. The Automatic implantable cardioverter defibrillator: The U.S. experience. In: P. Brugada, H.J. Wellens, eds. Cardiac arrhythmias: where to go from here? Futura Publishing Company, Inc., Mount Kisco, New York; 1987; p. 663-80.
29. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126. DOI:10.1093/eurheartj/ehac262
30. Maron BJ, Estes NAM, Rowin EJ, et al. Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2023;82(4):353-73. DOI:10.1016/j.jacc.2023.04.056
2. Lewis T. On the disturbances of the heartbeat in myocardial disease. Lancet. 1906;1:1249-52.
3. Cunningham RH. The cause of death from industrial accidents. NY Med J. 1899;70:581-7;615-22.
4. Herrick JB. Comments on the treatment of heart disease. JAMA. 1928;91(23):1761-3. DOI:10.1001/jama.1928.02700230001001
5. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912;LIX(23):2015-22. DOI:10.1001/jama.1912.04270120001001
6. Levine SA. Coronary thrombosis: its various clinical features. Baltimore: Williams & Wilkins, 1929.
7. Zoll PM, Linenthal AJ, Gibson W, et al. Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med. 1956;254:727-32. DOI:10.1056/NEJM195604192541601
8. Harrison TR, Resnik WH. Etiologic aspects of heart disease (including treatment of the different etiologic types). In: Harrison TR, Beeson PB, Thorn GW, et al. (eds). Principles of internal medicine. New York: Blackiston, 1950; p. 1287-9.
9. Braunwald E. The treatment of acute myocardial infarction: the Past, the Present, and the Future. Eur Heart J Acute Cardiovasc Care. 2012;1(1):9-12. DOI:10.1177/2048872612438026.
10. Rosenbaum MB, Chiale PA, Halpern MS, et al. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976;38(7):934-44. DOI:10.1016/0002-9149(76)90807-9
11. Hohnloser SH, Verrier RL, Lown B, et al. Effect of hypokalemia on susceptibility to ventricular fibrillation in the normal and ischemic canine heart. Am Heart J. 1986;112(1):32-5. DOI:10.1016/0002-8703(86)90674-5
12. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971;44(1):130-42. DOI:10.1161/01.cir.44.1.130
13. Zipes DP. Treatment of arrhythmias in myocardial infarction. Arch Intern Med. 1969;124(1):101-9. DOI:10.1001/archinte.1969.00300170103020
14. Killip T. Arrhythmias in Myocardial Infarction. Med Clin North Am. 1976;60(2):233-44. DOI:10.1016/s0025-7125(16)31907-1
15. Исаев Г.О., Васин А.А., Миронова О.Ю. Дефибрилляция: история и перспективы. Терапевтический архив. 2021;93(9):1138-43 [Isaev GO, Vasin AА, Mironova OI. History and perspectives of the defibrillation. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(9):1138-43 (in Russian)]. DOI:10.26442/00403660.2021.09.201030
16. Чазов Е.И., Николаева Л.Ф., Руда М.Я. Некоторые новые аспекты лечения больных острым инфарктом миокарда. Кардиология. 1977;(2):5-11 [Chazov EI, Nikolaeva LF, Ruda MYa. Some new aspects of the treatment of patients with acute myocardial infarction. Kardiologiya. 1977;(2):5-11 [(in Russian)].
17. Matchett M, Sears S, Hazelton G, et al. The implantable cardioverter defibrillator: its history, current psychological impact and future. Expert Rev Me Devices. 2009;6(1):43-50. DOI:10.1586/17434440.6.1.43
18. Stevenson WG, Desai AS, Almendral JM, et al. Multicenter Unsustained Tachycardia Trial Investigators. Catheter ablation of ventricular tachycardia in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial. Circulation. 2004;109(2):160-6.
19. Morady F, Harvey M, Kalbfleisch SJ, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993;87:363-72. DOI:10.1161/01.cir.87.2.363
20. Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. J Interv Card Electrophysiol. 2020;59(1):145-298. DOI:10.1007/s10840-019-00663-3
21. Scrocco C, Bezzina CR, Ackerman MJ, et al. Genetics and genomics of arrhythmic risk: current and future strategies to prevent sudden cardiac death. Nat Rev Cardiol. 2021;18(11):774-84. DOI:10.1038/s41569-021-00555-y
22. Чазов Е.И., ред. Инфаркт миокарда: Монография. М.: Медицина, 1971 [Chazov EI, red. Infarkt miokarda: Monografia. Moscow: Meditsina, 1971 (in Russian)].
23. Чазов Е.И., Матвеева Л.С., Мазаев А.В., и др. Внутрикоронарное назначение фибринолизина при остром инфаркте миокарда. Терапевтический архив. 1976;48(4):8-17 [Chazov EI, Matveeva LS, Mazaev AV, et al. Intracoronary fibrinolysin administration in acute myocardial infarction. Terapevticheskii Arkhiv (Ter. Arkh.). 1976;48(4):8-17 [(in Russian)].
24. Шахнович Р.М., Руда М.Я. Эволюция лечения инфаркта миокарда за последние десятилетия. Значение работ Е.И. Чазова. Терапевтический архив. 2019;91(6):25-33 [Shakhnovich RM, Ruda MYa. The evolution of myocardial infarction treatment over the past decades. The significance of E.I. Chazov works. Terapevticheskii Arkhiv (Ter. Arkh.). 2019;91(6):25-33 (in Russian)]. DOI:10.26442/00403660.2019.06.000291
25. Лебедев Д.С., Михайлов Е.Н., Неминущий Н.М., и др. Желудочковые нарушения ритма. Желудочковые тахикардии и внезапная сердечная смерть. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;26(7):4600 [Lebedev DS, Mikhailov EN, Neminuschiy NM, et al. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines. Russian Journal of Cardiology. 2021;26(7):4600 (in Russian)]. DOI:10.15829/1560-4071-2021-4600
26. Frampton J, Ortengren AR, Zeitler EP. Arrhythmias After Acute Myocardial Infarction. Yale J Biol Med. 2023;96(1):83-94. DOI:10.59249/LSWK8578
27. Campbell RW, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J. 1981;46(4):351-7. DOI:10.1136/hrt.46.4.351
28. Winkle RA, Thomas A. The Automatic implantable cardioverter defibrillator: The U.S. experience. In: P. Brugada, H.J. Wellens, eds. Cardiac arrhythmias: where to go from here? Futura Publishing Company, Inc., Mount Kisco, New York; 1987; p. 663-80.
29. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126. DOI:10.1093/eurheartj/ehac262
30. Maron BJ, Estes NAM, Rowin EJ, et al. Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2023;82(4):353-73. DOI:10.1016/j.jacc.2023.04.056
________________________________________________
2. Lewis T. On the disturbances of the heartbeat in myocardial disease. Lancet. 1906;1:1249-52.
3. Cunningham RH. The cause of death from industrial accidents. NY Med J. 1899;70:581-7;615-22.
4. Herrick JB. Comments on the treatment of heart disease. JAMA. 1928;91(23):1761-3. DOI:10.1001/jama.1928.02700230001001
5. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912;LIX(23):2015-22. DOI:10.1001/jama.1912.04270120001001
6. Levine SA. Coronary thrombosis: its various clinical features. Baltimore: Williams & Wilkins, 1929.
7. Zoll PM, Linenthal AJ, Gibson W, et al. Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med. 1956;254:727-32. DOI:10.1056/NEJM195604192541601
8. Harrison TR, Resnik WH. Etiologic aspects of heart disease (including treatment of the different etiologic types). In: Harrison TR, Beeson PB, Thorn GW, et al. (eds). Principles of internal medicine. New York: Blackiston, 1950; p. 1287-9.
9. Braunwald E. The treatment of acute myocardial infarction: the Past, the Present, and the Future. Eur Heart J Acute Cardiovasc Care. 2012;1(1):9-12. DOI:10.1177/2048872612438026.
10. Rosenbaum MB, Chiale PA, Halpern MS, et al. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976;38(7):934-44. DOI:10.1016/0002-9149(76)90807-9
11. Hohnloser SH, Verrier RL, Lown B, et al. Effect of hypokalemia on susceptibility to ventricular fibrillation in the normal and ischemic canine heart. Am Heart J. 1986;112(1):32-5. DOI:10.1016/0002-8703(86)90674-5
12. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971;44(1):130-42. DOI:10.1161/01.cir.44.1.130
13. Zipes DP. Treatment of arrhythmias in myocardial infarction. Arch Intern Med. 1969;124(1):101-9. DOI:10.1001/archinte.1969.00300170103020
14. Killip T. Arrhythmias in Myocardial Infarction. Med Clin North Am. 1976;60(2):233-44. DOI:10.1016/s0025-7125(16)31907-1
15. Isaev GO, Vasin AА, Mironova OI. History and perspectives of the defibrillation. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(9):1138-43 (in Russian). DOI:10.26442/00403660.2021.09.201030
16. Chazov EI, Nikolaeva LF, Ruda MYa. Some new aspects of the treatment of patients with acute myocardial infarction. Kardiologiya. 1977;(2):5-11 [(in Russian).
17. Matchett M, Sears S, Hazelton G, et al. The implantable cardioverter defibrillator: its history, current psychological impact and future. Expert Rev Me Devices. 2009;6(1):43-50. DOI:10.1586/17434440.6.1.43
18. Stevenson WG, Desai AS, Almendral JM, et al. Multicenter Unsustained Tachycardia Trial Investigators. Catheter ablation of ventricular tachycardia in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial. Circulation. 2004;109(2):160-6.
19. Morady F, Harvey M, Kalbfleisch SJ, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993;87:363-72. DOI:10.1161/01.cir.87.2.363
20. Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. J Interv Card Electrophysiol. 2020;59(1):145-298. DOI:10.1007/s10840-019-00663-3
21. Scrocco C, Bezzina CR, Ackerman MJ, et al. Genetics and genomics of arrhythmic risk: current and future strategies to prevent sudden cardiac death. Nat Rev Cardiol. 2021;18(11):774-84. DOI:10.1038/s41569-021-00555-y
22. Chazov EI, red. Infarkt miokarda: Monografia. Moscow: Meditsina, 1971 (in Russian).
23. Chazov EI, Matveeva LS, Mazaev AV, et al. Intracoronary fibrinolysin administration in acute myocardial infarction. Terapevticheskii Arkhiv (Ter. Arkh.). 1976;48(4):8-17 [(in Russian).
24. Shakhnovich RM, Ruda MYa. The evolution of myocardial infarction treatment over the past decades. The significance of E.I. Chazov works. Terapevticheskii Arkhiv (Ter. Arkh.). 2019;91(6):25-33 (in Russian). DOI:10.26442/00403660.2019.06.000291
25. Lebedev DS, Mikhailov EN, Neminuschiy NM, et al. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines. Russian Journal of Cardiology. 2021;26(7):4600 (in Russian). DOI:10.15829/1560-4071-2021-4600
26. Frampton J, Ortengren AR, Zeitler EP. Arrhythmias After Acute Myocardial Infarction. Yale J Biol Med. 2023;96(1):83-94. DOI:10.59249/LSWK8578
27. Campbell RW, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J. 1981;46(4):351-7. DOI:10.1136/hrt.46.4.351
28. Winkle RA, Thomas A. The Automatic implantable cardioverter defibrillator: The U.S. experience. In: P. Brugada, H.J. Wellens, eds. Cardiac arrhythmias: where to go from here? Futura Publishing Company, Inc., Mount Kisco, New York; 1987; p. 663-80.
29. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126. DOI:10.1093/eurheartj/ehac262
30. Maron BJ, Estes NAM, Rowin EJ, et al. Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2023;82(4):353-73. DOI:10.1016/j.jacc.2023.04.056
Авторы
Е.А. Окишева*1, Е.С. Пятигорец1, Д.Н. Окишев2, О.Ю. Трушина1
1ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия;
2ФГАУ «Национальный медицинский исследовательский центр нейрохирургии им. акад. Н.Н. Бурденко» Минздрава России, Москва, Россия
*e.okisheva@gmail.com
1Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
2Burdenko National Medical Research Center for Neurosurgery, Moscow, Russia
*e.okisheva@gmail.com
1ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия;
2ФГАУ «Национальный медицинский исследовательский центр нейрохирургии им. акад. Н.Н. Бурденко» Минздрава России, Москва, Россия
*e.okisheva@gmail.com
________________________________________________
1Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
2Burdenko National Medical Research Center for Neurosurgery, Moscow, Russia
*e.okisheva@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.